Delisting riskPopularity #4,063
PFSA · NASDAQ · Medical - Devices

Profusa (PFSA)

Injectable hydrogel biosensors and optical readers for continuous body-chemistry monitoring.

$1.91
After hours−0.26 (−12.18%)
At close$2.18(+12.11%)

In millions of USD, except per-share figures

In millionsQ4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Cost of revenue00000000000
Gross profit00000000000
010101122443
Research & development01000001111
010101021232
General & administrative01000100200
Other expenses00000010000
Operating income0−10−10−1−1−22−4−4−3
1−10−1−7−1−70−51−6
Interest income00000000000
Interest expense01010102102
Other non-operating income−1000707−15−10
Income before tax0−20−2−8−3−8−22−9−3−9
Income tax expense00000000000
Net income from continuing operations0−20−2−8−3−8−22−9−3−9
Net income0−20−2−8−3−8−22−9−3−9
EPS, basic$2.94−$10.22−$5.74−$96.61−$87.14−$7,881.91−$118.37−$52.45−$6.95−$2.05−$151.80
EPS, diluted$2.94−$10.22−$5.74−$96.61−$87.14−$7,881.91−$118.37−$52.45−$6.95−$2.05−$151.80
Weighted average shares, basic00000000120
Weighted average shares, diluted00000000120
EBITDA0−10−1−8−1−8−21−9−3−3
Depreciation & amortization00000000000
EBIT0−10−1−8−1−8−21−9−3−3